Hexagon Bio

United States
New Lisbon, Wisconsin, United States, 94025

Company profile

Hexagon Bio company profile

Hexagon Bio is a data-driven biotech developing targeted small molecule therapeutics. Our proprietary platform combines data science and synthetic biology to discover and engineer drugs from DNA sequences. We are mining fungal genomes for inspiration for the next generation of targeted therapies for diseases with unmet needs.

Business identity

Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$0-$1M
Founded
2016-01-01, Year

Headquarters

Postal code
94025
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
4
Total equity funding
$193.6M
Last funding
Series B / $77.3M / 2022-10-11
Last equity funding
Series B / $77.3M
Investors
10
Lead investors
3
Founders
2
Articles
16

Founders and investors

Founders

Maureen HillenmeyerYi Tang

Lead investors

8VCNextech InvestThe Column Group

Investors

8VCCasdin CapitalNextech InvestSoftBank Vision FundTwo Sigma Ventures